Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
04
2018
accepted:
20
02
2019
entrez:
14
3
2019
pubmed:
14
3
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Axshya SAMVAD is an active tuberculosis (TB) case finding (ACF) strategy under project Axshya (Axshya meaning 'free of TB' and SAMVAD meaning 'conversation') among marginalized and vulnerable populations in 285 districts of India. To compare patient characteristics, health seeking, delays in diagnosis and treatment initiation among new sputum smear positive TB patients detected through ACF and passive case finding (PCF) under the national TB programme in marginalized and vulnerable populations between March 2016 and February 2017. This observational analytic study was conducted in 18 randomly sampled Axshya districts. We enrolled all TB patients detected through ACF and an equal number of randomly selected patients detected through PCF in the same settings. Data on patient characteristics, health seeking and delays were collected through record review and patient interviews (at their residence). Delays included patient level delay (from eligibility for sputum examination to first contact with any health care provider (HCP)), health system level diagnosis delay (from contact with first HCP to TB diagnosis) and treatment initiation delays (from diagnosis to treatment initiation). Total delay was the sum of patient level, health system level diagnosis delay and treatment initiation delays. We included 234 ACF-diagnosed and 231 PCF-diagnosed patients. When compared to PCF, ACF patients were relatively older (≥65 years, 14% versus 8%, p = 0.041), had no formal education (57% versus 36%, p<0.001), had lower monthly income per capita (median 13.1 versus 15.7 USD, p = 0.014), were more likely from rural areas (92% versus 81%, p<0.002) and residing far away from the sputum microscopy centres (more than 15 km, 24% versus 18%, p = 0.126). Fewer patients had history of significant loss of weight (68% versus 78%, p = 0.011) and sputum grade of 3+ (15% versus 21%, p = 0.060). Compared to PCF, HCP visits among ACF patients was significantly lower (median one versus two HCPs, p<0.001). ACF patients had significantly lower health system level diagnosis delay (median five versus 19 days, p = 0.008) and the association remained significant after adjusting for potential confounders. Patient level and total delays were not significantly different. Axshya SAMVAD linked the most impoverished communities to TB care and resulted in reduction of health system level diagnosis delay.
Sections du résumé
BACKGROUND
Axshya SAMVAD is an active tuberculosis (TB) case finding (ACF) strategy under project Axshya (Axshya meaning 'free of TB' and SAMVAD meaning 'conversation') among marginalized and vulnerable populations in 285 districts of India.
OBJECTIVES
To compare patient characteristics, health seeking, delays in diagnosis and treatment initiation among new sputum smear positive TB patients detected through ACF and passive case finding (PCF) under the national TB programme in marginalized and vulnerable populations between March 2016 and February 2017.
METHODS
This observational analytic study was conducted in 18 randomly sampled Axshya districts. We enrolled all TB patients detected through ACF and an equal number of randomly selected patients detected through PCF in the same settings. Data on patient characteristics, health seeking and delays were collected through record review and patient interviews (at their residence). Delays included patient level delay (from eligibility for sputum examination to first contact with any health care provider (HCP)), health system level diagnosis delay (from contact with first HCP to TB diagnosis) and treatment initiation delays (from diagnosis to treatment initiation). Total delay was the sum of patient level, health system level diagnosis delay and treatment initiation delays.
RESULTS
We included 234 ACF-diagnosed and 231 PCF-diagnosed patients. When compared to PCF, ACF patients were relatively older (≥65 years, 14% versus 8%, p = 0.041), had no formal education (57% versus 36%, p<0.001), had lower monthly income per capita (median 13.1 versus 15.7 USD, p = 0.014), were more likely from rural areas (92% versus 81%, p<0.002) and residing far away from the sputum microscopy centres (more than 15 km, 24% versus 18%, p = 0.126). Fewer patients had history of significant loss of weight (68% versus 78%, p = 0.011) and sputum grade of 3+ (15% versus 21%, p = 0.060). Compared to PCF, HCP visits among ACF patients was significantly lower (median one versus two HCPs, p<0.001). ACF patients had significantly lower health system level diagnosis delay (median five versus 19 days, p = 0.008) and the association remained significant after adjusting for potential confounders. Patient level and total delays were not significantly different.
CONCLUSION
Axshya SAMVAD linked the most impoverished communities to TB care and resulted in reduction of health system level diagnosis delay.
Identifiants
pubmed: 30865730
doi: 10.1371/journal.pone.0213345
pii: PONE-D-18-10734
pmc: PMC6415860
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0213345Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2016 Jul 21;11(7):e0159579
pubmed: 27442529
Epidemiol Infect. 2008 Oct;136(10):1342-9
pubmed: 18177518
Int J Tuberc Lung Dis. 2013 Oct;17(10):1248-56
pubmed: 24025375
BMC Public Health. 2012 Jun 21;12:469
pubmed: 22720878
Am J Respir Crit Care Med. 2002 Apr 1;165(7):927-33
pubmed: 11934716
Public Health Action. 2017 Mar 21;7(1):74-77
pubmed: 28744430
Int J Tuberc Lung Dis. 2013 Apr;17(4):432-46
pubmed: 23485377
Public Health. 1998 May;112(3):165-8
pubmed: 9629023
Public Health Action. 2016 Mar 21;6(1):15-8
pubmed: 27051605
JAMA. 1996 Oct 16;276(15):1223-8
pubmed: 8849749
Bull World Health Organ. 2006 Feb;84(2):112-9
pubmed: 16501728
Int J Tuberc Lung Dis. 2017 Jan 1;21(1):73-78
pubmed: 28157468
Glob Health Action. 2018;11(1):1494897
pubmed: 30173603
Lancet. 2013 Oct 5;382(9899):1183-94
pubmed: 23915882
PLoS One. 2015 Jul 29;10(7):e0130179
pubmed: 26222545
Int J Tuberc Lung Dis. 2003 Mar;7(3):258-65
pubmed: 12661841
Int J Tuberc Lung Dis. 2014 Mar;18(3):255-266
pubmed: 24670558
Shanghai Arch Psychiatry. 2014 Apr;26(2):105-9
pubmed: 25092958
Acta Trop. 2016 Sep;161:106-13
pubmed: 27311390
Indian J Med Res. 2012 May;135(5):690-4
pubmed: 22771603
BMC Med. 2017 Mar 3;15(1):47
pubmed: 28253922
PLoS One. 2013 Jun 27;8(6):e67516
pubmed: 23826313
Int J Tuberc Lung Dis. 2010 Jun;14(6):720-6
pubmed: 20487610
BMC Public Health. 2017 Aug 4;17(1):635
pubmed: 28778192
BMJ Open. 2014 Jun 10;4(6):e004818
pubmed: 24916087
Indian J Tuberc. 2016 Jul;63(3):199-202
pubmed: 27865243